|
Session Descriptions
Pharmaceutical Waste: New Focus, New Opportunities
8:45 AM—9:45 AM
The pharmaceutical industry, including manufacturers, distributors and pharmacies, is among the most highly regulated in the nation. Yet, there is a continuing interest in understanding the effects of the final disposition of waste pharmaceuticals. Learn more about:
- “Pharmaceuticals in the Environment”
- Initiatives at EPA & DEA
- Public health issues
- Affects on reverse distribution
- Action items for supply chain partners
Also, delve into issues such as endocrine disruption, pharmaceuticals in drinking water and their relation to the healthcare supply chain. Look at EPA regulations affecting pharmaceutical waste management from manufacturing through distribution and consumer take-back programs. Explore DEA regulations and proposals to modify current practices. Discuss new models for managing short-dated medications and unused consumer medicines, and how public health and funding issues may ultimately take on greater significance.
Keynote Speaker: Charlotte A. Smith, President, PharmEcology Associates, LLC
Preventing or Reducing Returns at the Retail Level
10:15 AM—11:15 AM
A panel of retail experts will discuss and explore ways to prevent or reduce returns at retail level. Key discussion points will include:
- The latest information on new product introductions, loss of patents, generic conversions and dating of products in the pipeline;
- Strategies for preventing returns at the retail level;
- Results and benefits from returns processes already implemented; and
- Recommendations on how to address retail-level inventory management challenges.
Moderator: Jennifer Mauldin, Executive Vice President, MedTurn, Inc.
Panelist: Ed Crimmins, Senior Director, Pharmacy Returns, Rite Aid Corporation; Joe Harmison, President, Harmison Pharmacies
Biotech and Specialty Returns
11:15 AM—12:00 PM
A panel of experts will discuss how the increase in biotechnology and specialty products in the marketplace presents a unique set of challenges and opportunities in returns. Key discussion points will include:
- Customer service channels and challenges;
- Perspectives from the supply chain on unique product attributes and delivery requirements for specialty and biotech medicines, including cold chain;
- Discussion of how return rates vary by type of product, the channel and the type of administration;
- How restricted distribution requirements affect the supply chain and the ultimate customer;
- Returns implications for purchasing; and
- The returns data currently available, and how to obtain and measure that data to improve business processes.
Panelists: Linda Castanon, Pharmaceutical Distribution Warehouse Manager, US Oncology; Wade Goodhart, Director, Managed Distribution, McKesson Specialty Care Solutions
Panel Discussion: Logistics Practices and Data Sharing
1:20 PM—2:30 PM
Logistics experts will discuss improvements in the shipment of returned products and other operations practices. Learn how to streamline the reverse logistics process by improving the flow of information and accelerating the credit process. Hear fresh perspectives from industry experts on standardized information templates and EDI data elements that can be used to enhance operational efficiencies, including reference number, return date and unit of measure.
Moderator: Daniel J. Raftery, President, Raftery Resource Network
Panelists: Rex Hall, Returns Solutions Manager, AmerisourceBergen; Susan Jackson, Director, Customer Operations, Specialty Pharmaceutical Services, Cardinal Health, Inc.; Bob Weston, Customer Service/Logistics Manager, Procter & Gamble Pharmaceuticals
Panel Discussion: End of Life: Disposition, Destruction, Donation
2:30 PM—3:30 PM
After pharmaceutical waste was discovered in the U.S. drinking water supply, legislators, regulators, industry and the public increased attention on responsible treatment of discarded and returned prescription medicines. This session will examine the issues surrounding the appropriate disposal of pharmaceuticals, including strategies for product donation, different challenges associated with waste product and consumer-focused pilot “take-back” programs already underway. Learn how trading partners are creating alliances, working with government agencies to streamline solutions for the industry.
Moderator: Charlotte A. Smith, President, PharmEcology Associates, LLC
Panelists: Alice Chapman, PE Local Hazardous Waste Management Program, King County, WA; Joanne Cooper, Corporate Relations, AmeriCares Foundation; Nadine You, Vice President, Corporate Operations, EXP Pharmaceutical Returns
|
